{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:16:40Z","timestamp":1794410200362,"version":"4.9.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32 DK063688"],"award-info":[{"award-number":["T32 DK063688"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["F32DK128970"],"award-info":[{"award-number":["F32DK128970"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013355","name":"Center for Protein Therapeutics, University at Buffalo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013355","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002108","name":"Friedreichs Ataxia Research Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.diabres.2022.109828","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T19:10:26Z","timestamp":1647285026000},"page":"109828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Friedreich\u2019s Ataxia related Diabetes: Epidemiology and management practices"],"prefix":"10.1016","volume":"186","author":[{"given":"Jaclyn","family":"Tamaroff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"DeDio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"McKenzie","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karla","family":"Leavens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Rummey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shana E.","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.diabres.2022.109828_b0005","doi-asserted-by":"crossref","first-page":"7452","DOI":"10.1073\/pnas.94.14.7452","article-title":"Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations","volume":"94","author":"Cossee","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"3","key":"10.1016\/j.diabres.2022.109828_b0010","first-page":"554","article-title":"The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia","volume":"59","author":"Filla","year":"1996","journal-title":"Am J Hum Genetics"},{"issue":"2","key":"10.1016\/j.diabres.2022.109828_b0015","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/1531-8249(199902)45:2<200::AID-ANA10>3.0.CO;2-U","article-title":"Friedreich's ataxia: point mutations and clinical presentation of compound heterozygotes","volume":"45","author":"Coss\u00e9e","year":"1999","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1016\/j.diabres.2022.109828_b0020","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09989-y","article-title":"Structure of the human frataxin-bound iron-sulfur cluster assembly complex provides insight into its activation mechanism","volume":"10","author":"Fox","year":"2019","journal-title":"Nat Commun"},{"issue":"1-2","key":"10.1016\/j.diabres.2022.109828_b0025","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jns.2011.05.023","article-title":"Mortality in Friedreich ataxia","volume":"307","author":"Tsou","year":"2011","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/j.diabres.2022.109828_b0030","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1002\/ana.23698","article-title":"Central role and mechanisms of beta-cell dysfunction and death in friedreich ataxia-associated diabetes","volume":"72","author":"Cnop","year":"2012","journal-title":"Ann Neurol"},{"issue":"1-2","key":"10.1016\/j.diabres.2022.109828_b0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jns.2014.04.015","article-title":"Cross-sectional analysis of glucose metabolism in Friedreich ataxia","volume":"342","author":"Greeley","year":"2014","journal-title":"J Neurol Sci"},{"issue":"9","key":"10.1016\/j.diabres.2022.109828_b0040","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/acn3.439","article-title":"Impact of diabetes in the Friedreich ataxia clinical outcome measures study","volume":"4","author":"McCormick","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"issue":"1","key":"10.1016\/j.diabres.2022.109828_b0045","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/acn3.686","article-title":"OGTT is recommended for glucose homeostasis assessments in Friedreich ataxia","volume":"6","author":"Azzi","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"issue":"9","key":"10.1016\/j.diabres.2022.109828_b0050","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1177\/0883073812448462","article-title":"Friedreich ataxia clinical outcome measures: natural history evaluation in 410 participants","volume":"27","author":"Regner","year":"2012","journal-title":"J Child Neurol"},{"issue":"9","key":"10.1016\/j.diabres.2022.109828_b0055","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/acn3.332","article-title":"Progression of Friedreich ataxia: quantitative characterization over 5 years","volume":"3","author":"Patel","year":"2016","journal-title":"Ann Clin Transl Neurol"},{"issue":"9","key":"10.1016\/j.diabres.2022.109828_b0060","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/acn3.51118","article-title":"Test-retest reliability of the Friedreich's ataxia rating scale","volume":"7","author":"Rummey","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"issue":"6","key":"10.1016\/j.diabres.2022.109828_b0065","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1212\/NXG.0000000000000371","article-title":"Psychometric properties of the Friedreich Ataxia Rating Scale","volume":"5","author":"Rummey","year":"2019","journal-title":"Neurol Genetics"},{"issue":"2","key":"10.1016\/j.diabres.2022.109828_b0070","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"issue":"3","key":"10.1016\/j.diabres.2022.109828_b0075","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2337\/diacare.28.3.626","article-title":"Assessing psychosocial distress in diabetes: development of the diabetes distress scale","volume":"28","author":"Polonsky","year":"2005","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.diabres.2022.109828_b0080","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/jpepsy\/jsz018","article-title":"Psychometric Properties of the Parent and Child Problem Areas in Diabetes Measures","volume":"44","author":"Evans","year":"2019","journal-title":"J Pediatr Psychol."},{"issue":"5","key":"10.1016\/j.diabres.2022.109828_b0085","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/jpepsy\/jsx146","article-title":"Psychometric Properties of the Problem Areas in Diabetes: Teen and Parent of Teen Versions","volume":"43","author":"Shapiro","year":"2018","journal-title":"J Pediatr Psychol."},{"issue":"6","key":"10.1016\/j.diabres.2022.109828_b0090","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1212\/NXG.0000000000000638","article-title":"Body Mass Index and Height in the Friedreich Ataxia Clinical Outcome Measures Study","volume":"7","author":"Patel","year":"2021","journal-title":"Neurol Genetics"},{"issue":"10","key":"10.1016\/j.diabres.2022.109828_b0095","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00125-019-4939-5","article-title":"Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course","volume":"62","author":"Huebschmann","year":"2019","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.diabres.2022.109828_b0100","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1002\/acn3.51352","article-title":"Scoliosis in Friedreich's ataxia: longitudinal characterization in a large heterogeneous cohort","volume":"8","author":"Rummey","year":"2021","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.diabres.2022.109828_b0105","unstructured":"Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Atlanta, GA: Centers for Disease Control and Prevention, U.S. Dept of Health and Human Services; 2020. [Internet]."},{"key":"10.1016\/j.diabres.2022.109828_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2019.11.006","article-title":"Predictors of loss of ambulation in Friedreich's ataxia","volume":"18","author":"Rummey","year":"2020","journal-title":"EClinicalMedicine"},{"issue":"10","key":"10.1016\/j.diabres.2022.109828_b0115","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.2337\/diacare.26.10.2791","article-title":"Diabetes and idiopathic cardiomyopathy: a nationwide case-control study","volume":"26","author":"Bertoni","year":"2003","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.diabres.2022.109828_b0120","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.cardfail.2010.05.027","article-title":"Impaired glucose tolerance and insulin resistance in heart failure: underrecognized and undertreated?","volume":"16","author":"Mamas","year":"2010","journal-title":"J Cardiac Fail"},{"issue":"21","key":"10.1016\/j.diabres.2022.109828_b0125","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"New Eng J Medicine"},{"key":"10.1016\/j.diabres.2022.109828_b0130","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.diabres.2018.05.008","article-title":"Diabetes mellitus in Friedreich Ataxia: A case series of 19 patients from the German-Austrian diabetes mellitus registry","volume":"141","author":"Pappa","year":"2018","journal-title":"Diabetes Res Clin Pract."},{"issue":"3","key":"10.1016\/j.diabres.2022.109828_b0135","doi-asserted-by":"crossref","first-page":"636","DOI":"10.2337\/diacare.25.3.636","article-title":"Increased Risk of Diabetes in First-Degree Relatives of Young-Onset Type 2 Diabetic Patients Compared With Relatives of Those Diagnosed Later","volume":"25","author":"Owen","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2022.109828_b0140","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.redox.2017.08.018","article-title":"Metformin selectively targets redox control of complex I energy transduction","volume":"14","author":"Cameron","year":"2018","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.diabres.2022.109828_b0145","doi-asserted-by":"crossref","first-page":"107584","DOI":"10.1016\/j.jdiacomp.2020.107584","article-title":"Management of mitochondrial diabetes in the era of novel therapies","volume":"35","author":"Yeung","year":"2021","journal-title":"J Diabetes Complications."},{"issue":"8","key":"10.1016\/j.diabres.2022.109828_b0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0221174","article-title":"National ambulatory care non-insulin antidiabetic medication prescribing trends in the United States from 2009 to 2015","volume":"14","author":"Kitten","year":"2019","journal-title":"PLOS ONE"},{"issue":"9","key":"10.1016\/j.diabres.2022.109828_b0155","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2337\/dc15-0843","article-title":"Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium-Glucose Cotransporter 2 Inhibition","volume":"38","author":"Peters","year":"2015","journal-title":"Diabetes Care"},{"issue":"6","key":"10.1016\/j.diabres.2022.109828_b0160","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00125-008-0983-2","article-title":"N of 1 trials in diabetes: making individual therapeutic decisions","volume":"51","author":"Tsapas","year":"2008","journal-title":"Diabetologia"},{"issue":"7","key":"10.1016\/j.diabres.2022.109828_b0165","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11892-018-1012-6","article-title":"Identifying Prediabetes and Type 2 Diabetes in Asymptomatic Youth: Should HbA1c Be Used as a Diagnostic Approach?","volume":"18","author":"Vajravelu","year":"2018","journal-title":"Curr Diab Rep."},{"key":"10.1016\/j.diabres.2022.109828_b0170","doi-asserted-by":"crossref","unstructured":"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021. Diabetes care. 2021;44(Suppl 1):S111-s24. doi: 10.2337\/dc21-S009. PMID: 33298420.","DOI":"10.2337\/dc21-S009"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722006404?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822722006404?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:52:11Z","timestamp":1777510331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822722006404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":34,"alternative-id":["S0168822722006404"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109828","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Friedreich\u2019s Ataxia related Diabetes: Epidemiology and management practices","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2022.109828","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109828"}}